Approval · Notice of Compliance 18100 · 2016
ZONTIVITY: Notice of Compliance 18100
Issued May 13, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18100
- Date
- May 13, 2016
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZONTIVITY | 02454815 | Cancelled Pre Market |
Medicinal ingredients
- VORAPAXAR SULFATE 2.5 MG per TAB